Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia.

Area of Science:

• Neuroscience
• Psychiatry
• Neurochemistry

Background:

• Glutamatergic neurotransmission plays a crucial role in brain function.
• Dysregulation of glutamatergic systems has been implicated in schizophrenia pathogenesis.
• Specific glutamate receptors and uptake sites are key targets for investigation.

Purpose of the Study:

• To investigate glutamatergic mechanisms in postmortem brain samples from individuals with schizophrenia compared to controls.
• To examine D-[3H]aspartate binding as a marker for glutamatergic neurons and [3H]kainate binding for postsynaptic glutamate receptors.

Main Methods:

• Utilized postmortem brain tissue from schizophrenic patients and healthy controls.
• Assessed D-[3H]aspartate binding to glutamate uptake sites.
• Measured [3H]kainate binding to specific glutamate receptors.

Main Results:

• Significantly increased binding of both D-[3H]aspartate and [3H]kainate was observed in the orbital frontal cortex (both left and right hemispheres) of schizophrenic brains.
• These changes were unlikely due to neuroleptic treatment, as other brain regions showed no similar alterations.
• A hypothesized left-sided reduction in D-[3H]aspartate binding was not statistically supported.
• In schizophrenics, high dopamine levels in the left amygdala correlated with low D-[3H]aspartate binding in the left polar temporal cortex.

Conclusions:

• The findings suggest an overabundant glutamatergic innervation of the orbital frontal cortex in schizophrenia.
• Schizophrenia may involve left-sided abnormalities in the interplay between temporal glutamatergic and dopaminergic projections to the amygdala.